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011.09.0Abstract Introduction: Left ventricular hypertrophy (LVH) is a major cardiovascular risk factor
in patients on maintenance hemodialysis (HD). The aim of our study is to ﬁnd correlation between
ankle brachial index (ABI), carotid intima media thickness (IMT) and left ventricular hypertrophy
in this population.
Patient and methods: Twenty consecutive patients on maintenance hemodialysis were studied, all
clinical data were included and laboratory data recorded, three most recent pre-dialysis blood pres-
sure measurements were recorded and averaged. Ankle brachial index, also carotid intima media
thickness were measured for all patients echocardiography to asses left ventricular wall thickness
mainly was done.
Results: There was positive correlation between IMT and LVH as well as a negative correlation
between ABI and LVH in those patients on hemodialysis.
Both parameters were correlated with BMI and serum albumin. When serum albumin level rise,
ABI increase and IMT decrease indicating no atherosclerotic changes. Left ventricular mass index
(LVMI) was also highly negatively correlated with serum albumin. Obesity was found to be asso-
ciated with more atherosclerotic changes with rise of IMT and lowering of ABI in our work, but not
correlated with LVMI. Systolic blood pressure (SBP) was also correlated with more atheroscleroticom (K.A. Fouad).
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142 H.A. Hebah, K.A. Fouadchanges with higher IMT and lower ABI and positively correlated with LVH.
Conclusion: Both ABI and carotid IMT are equally effective to predict cardiovascular risk as
regard to LVH in hemodialysis population and ABI should be included as a bed side cheap and
reliable way to assess cardiovascular risk in hemodialysis patients.
ª 2011 Egyptian Society of Cardiology. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Cardiovascular diseases are the most frequent cause of death
among hemodialysis patients with sudden cardiac death
accounting for between 10% and 30% of deaths from all
causes. Left ventricular hypertrophy (LVH) is a potent predic-
tor of cardiovascular morbidity and mortality in those
patients.10
Being present in 40% of patients with chronic renal insufﬁ-
ciency and in 75% of patients starting dialysis, LVH represent
a key prognostic factor and can predict development of heart
failure and ischemic heart disease.11
In addition, a fall in left ventricular mass index or a rise in
fractional shortening in the ﬁrst year of dialysis therapy was
associated with a lower probability of new onset cardiac
failure.11
Peripheral vascular disease (PVD) is more common among
patients with end-stage renal disease (ESRD) than in the gen-
eral population. Prevalence rates cited in the literature range
from 17% to 48%, depending on the ESRD population stud-
ied and the diagnostic methods used. The presence of PVD
substantially increases the risk for both morbidity (chronic
ischemic ulceration, gangrene, and amputation) and death
among ESRD patients.12 They also demonstrated that LVH
in maintenance hemodialysis patients was associated with
peripheral vascular disease.
Prediction of major cardiovascular and cerebrovascular
events using conventional risk factor models is limited. Both
carotid intima-media thickness (IMT), and ankle-brachial
pressure index (ABI) are noninvasive subclinical markers asso-
ciated with coronary artery disease.2
They could improve risk prediction and provide more fo-
cused primary prevention strategies.3
The ABI was originally used to identify lower-limb athero-
sclerosis. However, it has subsequently been shown to be an
accurate and reliable marker of generalized atherosclerosis.14
Previous cross-sectional studies have demonstrated signiﬁ-
cant associations between the ankle-brachial index (ABI) and
carotid intimal media thickness (IMT) in diabetic subjects5
but up to our knowledge correlation between ankle brachial
index, carotid intima media thickness, and left ventricular
hypertrophy in ESRD were not studied.
2. Aim
Our aim was to assess ankle brachial index (ABI) and carotid
intima-media thickness (IMT) and their correlation to left ven-
tricular hypertrophy in hemodialysis patients.
3. Patients and method
Twenty patients on regular hemodialysis in our unit perform-
ing 3 sessions/week with bicarbonate dialysis were included inour study. All clinical data, including name, gender, age,
smoking history (ever versus never), underlying disease, co-
morbid conditions, duration of dialysis were obtained.
Hemoglobin, serum albumin, C-reactive protein, calcium,
phosphorus, total cholesterol, total triglycerides, low density
lipoprotein, high density lipoprotein and pre and post-dialysis
urea were recorded. Three most recent pre-dialysis blood pres-
sure measurements were recorded and averaged.
Kt/V was calculated by using the formula: Kt/V=
((0.026 · average urea reduction ratio)  0.46).
3.1. Ankle brachial index measurement
All participants were required to rest in supine position for
5 min before ABI measurement. A blood pressure cuff of
appropriate size was wrapped over non ﬁstula brachial artery
and above each malleolus. Cuff is rapidly inﬂated to 20 mmHg
above the audible systolic pressure in non ﬁstula arm and de-
ﬂated at a rate of 2 mm/s. The systolic pressure was recorded
as the pressure at which the ﬁrst sustained systolic pressure
was audible. We used an ultrasound machine HDI5000
(ATL-Philips, Bothell, WA, USA) and 5 MHz Doppler probe.
Ankle brachial index is calculated by the ratio of the ankle
systolic pressure divided by the arm systolic pressure. An ABI
between 0.9 and 1.3 is deﬁned normal, less than 0.9 is classiﬁed
as peripheral arterial disease.
3.2. Echocardiography
Transthoracic echocardiography (2D and M mode) was done
to all patients to assess left ventricular dimension and function,
interventricular septum and posterior wall thickness.
LVMI was calculated as: LVM/body surface area (m2).
LVM
(g) = 1.04((LVDd + IVST + PWT)3  (LVDd)3  13.6.
LVH is deﬁned as LVMIP 134 g/m2 for male patients and
LVMIP 110 g/m2 for female.
3.3. Carotid intima media thickness
The degree of carotid atherosclerosis was evaluated ultrasono-
graphically by an experienced sonographer using an 8–15 MHz
scanner. The maximum intimal-medial thickness indicates the
maximum wall thickness of the whole carotid arteries.
3.4. Statistical analysis
We used the Statistical Package for Social Sciences for Win-
dows, version 10.0 soft ware package. Mean differences be-
tween the LVH group and the non LVH group was assessed
with the student t-test for the normal data and Wilcoxon rank
sum test for the non normal data. Pearson correlation coefﬁ-
cient was used to examine correlation between variables.
Correlation between ankle brachial index, carotid intima media thickness and left ventricular hypertrophy 143Multiple regression analysis was used to assess independent
association between one dependent and two or more indepen-
dent variables. All measurement data were expressed as
mean ± SD. P value < 0.05 was considered to indicate signif-
icance and P value < 0.01 to indicate highly signiﬁcant result.
4. Results
Twenty patients with age 45.45 ± 13.48 (25–70) on MHD of
32.7 ± 18.87 (7–67) month’s duration were studied. They were
divided into two groups according to presence or absence of
LVH (left ventricular hypertrophy). Eleven patients were in
group of LVH and 9 patients had no ventricular hypertrophy.
There is signiﬁcant difference between the two groups as re-
gard SBP, serum Alb level, serum TGs, HDL, ABI, IMT and
echocardiographic data of IVSTd, LVPWTd and EF but no
statistical difference with serum calcium, phosphorus, Ca · P
product, BMI, duration of dialysis, dialysis adequacy between
the two groups (Table 1).
Bivariate analysis showed that LVMI was negatively corre-
lated with ABI, HDL and serum calcium (r= 0510, 0.495,
0.539, P< 0.05) and with albumin (r= 0.692, P< 0.01).
LVMI was positively correlated with IMT, TGs DBP
(r= 0.486, 0.508, 0.446, P< 0.05) and with SBP (r= 0.590,
P< 0.01). No correlation with Kt/V, CRP, P, LDL, Hb,
smoking or duration of dialysis (Table 2). For ABI for hemod-Table 1 Characteristics of LVH group versus non LVH group in M
Variable LVH group
Number 11
Age (years) 50.73 ± 13.78
Duration of dialysis (months) 38.09 ± 20.1
BMI 24.8 ± 4.32
SBP (mmHg) 141.36 ± 14.85
DBP (mmHg) 85.45 ± 11.93
HR (b/min) 82.55 ± 8.44
Hb (g/dl) 10.19 ± 1.42
Alb (mg/dl) 3.64 ± 0.4
T. CHOL (mg/dl) 178.00 ± 32.2
TGs (mg/dl) 169.64 ± 58.57
HDL (mg/dl) 34.64 ± 6.83
LDL (mg/dl) 107.27 ± 19.12
Ca (mg/dl) 8.91±1.05
Ph (mg/dl) 6.01 ± 1.99
Ca · P (mg2/dl2) 53.97 ± 19.35
CRP (mg/dl) 13.14 ± 6.45
ABI 0.757 ± 0.247
IMT 1.282 ± 0.197
EF% 56.34 ± 11.11
LVMI (g/m2) 164.57 ± 28.08
IVSTd 15.027 ± 1.7
LVPWTd 12.809 ± 1.3
Kt/V 0.99 ± 0.27
HTN (%) 72.72%
DM (%) 54.54%
Smoking (%) 54.54%
Male/female 7/4
* P< 0.05.
** P< 0.01. ABI, ankle brachial index; IMT, intima media thickness; BM
blood pressure; DBP, diastolic blood pressure; EF, ejection fraction; H
IVSTd, interventricular septal diameter; LVPWTd, left ventricular post
reactive protein.ialysis patients Table 3 showed signiﬁcant negative correlation
with LVMI, SBP (r= 0.510, 0.496, P< 0.05) and a highly
signiﬁcant reverse correlation with IMT and BMI
(r= 0.751, 0.608, P< 0.01). A highly signiﬁcant positive
correlation was found with serum albumin (r= 0.592,
P< 0.01). No correlation with Kt/V, CRP, Ca · P, lipid pro-
ﬁle, HR, Hb, duration of dialysis or smoking.
Carotid IMT was positively correlated with LVMI, SBP,
BMI (r= 0.486, 0.486, 0.551, P< 0.05).
And highly negatively correlated with ABI (r= 0.751,
P< 0.01) and with serum albumin (r= 0.471, P< 0.05).
No correlation with Kt/V, CRP, Ca · P, P, lipid proﬁle, HR,
Hb, duration of dialysis or smoking (Table 4).
Table 5 shows the results of multiple linear regression tests.
There is signiﬁcant predictive value of ABI (P= 0.022) and
carotid IMT (P= 0.030) as well as SBP (P= 0.006) and
DBP (P= 0.049) in predicting LVMI. Kt/V, serum hemoglo-
bin level failed to show this relation.
5. Discussion
The risk of cardiovascular death is 10 times higher in patients
with end stage renal disease (ESRD) than in the general pop-
ulation. This higher death rate may be attributable to patho-
physiologic causes leading to advanced atherosclerotic
changes of the arterial wall and left ventricular hypertrophy.9HD patients.
Non LVH group P value
9
39 ± 10.44 0.050
26.11 ± 15.86 0.163
22.4 ± 1.67 0.135
126.67 ± 10.0 0.021*
80.56 ± 9.82 0.337
77.33 ± 8.19 0.181
10.8 ± 1.51 0.363
4.07 ± 0.25 0.013*
158.44 ± 25.7 0.157
110.44 ± 36.04 0.017*
42.78 ± 4.52 0.007**
99.67 ± 16.37 0.358
9.72 ± 1.21 0.125
4.94 ± 1.54 0.204
47.98 ± 15.28 0.460
10.32 ± 4.86 0.293
1.084 ± 0.123 0.002**
0.932 ± 0.239 0.002**
68.014 ± 5.087 0.01*
101.00 ± 7.5 0.000**
11.21 ± 1.06 0.000**
9.25 ± 3.25 0.004**
1.09 ± 0.23 0.393
33.33% 0.086
11.1% 0.048*
22.22% 0.152
5/4 0.721
I, body mass index; LVMI, left ventricular mass index; SBP, systolic
b, hemoglobin; HR, heart rate; MHD, maintenance hemodialysis;
erior wall diameter; Ca · P, calcium phosphorus product; CRP, C
Table 3 Correlation coefﬁcients for ABI and other variables
in MHD patients.
Variable R P
LVMI 0.510 0.022
Kt/V 0.022 0.925
IMT 0.751 0.000
EF 0.643 0.002
IVSTd 0.616 0.004
CRP 0.091 0.702
Ca · P 0.008 0.973
P 0.057 0.811
Ca 0.119 0.617
CHOL. 0.064 0.789
LDL 0.023 0.922
HDL 0.318 0.172
TG 0.210 0.374
Hb 0.347 0.134
HR 0.372 0.106
DBP 0.280 0.232
SBP 0.496 0.026
BMI 0.608 0.004
Smoking 0.030 0.900
DD 0.176 0.458
Alb 0.592 0.006
Table 2 Correlation coefﬁcients for LVMI and other vari-
ables in MHD patients.
Variables R P
Kt/V 0.02 0.932
IMT 0.486 0.030
ABI 0.510 0.022
EF 0.685 0.001
IVSTd 0.639 0.002
CRP 0.174 0.463
Ca · P 0.025 0.916
P 0.155 0.514
Ca 0.539 0.014
LDL 0.226 0.338
HDL 0.495 0.026
TG 0.508 0.022
Hb 0.442 0.051
DBP 0.446 0.049
SBP 0.590 0.006
HR 0.169 0.476
BMI 0.379 0.099
Smoking 0.058 0.807
DD 0.106 0.658
CHOL 0.185 0.436
Alb 0.692 0.001
Table 4 Correlation coefﬁcient for IMT and other variables
in MHD patients.
Variable R P
LVMI 0.486 0.030
Kt/V 0.142 0.549
ABI 0.751 0.000
EF 0.460 0.041
IVSTd 0.692 0.001
CRP 0.070 0.768
Ca · P 0.015 0.951
P 0.080 0.738
Ca 0.183 0.440
CHOL. 0.2 0.397
LDL 0.122 0.609
HDL 0.237 0.315
TG 0.410 0.072
SBP 0.486 0.030
DBP 0.197 0.405
HR 0.351 0.129
Hb 0.409 0.073
Smoking 0.205 0.385
DD 0.371 0.107
Alb 0.471 0.036
BMI 0.551 0.012
Table 5 The results of multiple linear regression analysis for
predicting LVMI.
Variables Standardised b P value
IMT 0.486 0.030
ABI 0.510 0.022
Kt/V 0.020 0.932
SBP 0.590 0.006
DBP 0.446 0.049
Hb 0.442 0.51
Alb 0.692 0.090
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mass (LVM) increases progressively as renal function deterio-
rates,11 and in a substantial number of cases this trend is not
arrested.11 Partial regression of LVH occurs only after renal
transplantation.
The major ﬁnding in the study of Paoletti et al.10 is that the
worsening of pre-existing LVH, independent of the absolute
LVMI values at inception, is the strongest predictor of the risk
of sudden cardiac death (SCD) in dialysis patients. In this pop-
ulation, LVH has been found to be associated with lower actu-arial survival rates probably because LVH is progressive and
continues after the initiation of dialysis treatment .In hemodi-
alysis patients, long-lasting arterial hypertension and pre-exist-
ing IHD were demonstrated to also be correlates of SCD.
However, the worsening of LVH turned out to be the most sig-
niﬁcant predictor when all the putative factors were examined
together by multivariate analysis. This result reﬂects a peculiar
picture of dialysis patients, since the increase in LVMI is even a
stronger predictor of SCD than IHD itself, which, on the con-
trary, is associated with SCD in 80% of cases in the general
population.
Peripheral arterial disease (PAD) patients are at high risk of
cardiac death. Coincidental but silent coronary disease is obvi-
ously a major contributor but left ventricular hypertrophy
(LVH) could be a second major contributor.
Interest is increasing in the use of non invasive markers that
allow the identiﬁcation of subclinical cardiac disease including
the ankle brachial index (ABI) and carotid intima media thick-
ness (IMT). A low ABI has now been shown to be an accurate
and reliable marker of generalized atherosclerosis and a good
predictor of subsequent cardiovascular morbidity and
mortality.3
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otid IMT and the incidence of cardiovascular events, ﬁnding
an independent relationship between a raised IMT and an in-
creased risk of events.14
In our study we found that LVMI was positively correlated
with intima media thickness (IMT), triglycerides level, systolic
and diastolic blood pressure (SBP and DBP). It is negatively
correlated with ankle brachial index (ABI), calcium level,
HDL and serum albumin level. Wencheng et al.1 found also
correlation with hypertension, and same negative correlation
with ABI and albumin level, but with calcium it was positively
correlated. They found no correlation between LVMI and lipid
levels and they correlated LVMI also to CRP, hemoglobin,
phosphorus and calcium phosphorus product. In our study
there was negative correlation with hemoglobin level but was
of no statistical difference, this may be related to the wide
use of erythropoietin for anemia treatment. Although struc-
tural LV alterations occur early during the course of renal dis-
ease and result in large part from volume and pressure
overloads, several studies demonstrated that renal anemia,
inﬂammatory status, protein malnutrition and disorders of cal-
cium phosphorus metabolism played a role in the development
of LVH in MHD patients, this will be different according to
the population studied in each time.
Although peripheral atherosclerosis and increased arterial
wall stiffness are closely correlated with LVH, no study has
compared the relationship between ABI and carotid IMT in
relation to LVH in patients on maintenance hemodialysis.
Ono et al.13 found that ABI was reversely correlated with
all cause and cardiovascular mortality in hemodialysis
patients.
Our work showed that ABI was correlated with serum albu-
min as well there was negative correlation between serum albu-
min and IMT, same correlation is found in work of Wencheng
et al.1 between albumin level and ABI.
It has been shown that hypoalbuminemia is pathogenically
associated with vascular disease.
(Effect dissociated from protein malnutrition in patients
with ESRD), but protein malnutrition and hypoalbuminemia
are both predictive of mortality in patients on dialysis.7 The
odds for atherosclerosis linearly decreased as albumin level
increased and patients with low albumin on chronic hemodial-
ysis had signiﬁcantly greater coronary artery disease.6
ABI was negatively correlated with LVMI and its value in
the LVH group was signiﬁcantly lower than that in the non
LVH group, same negative correlation also between ABI and
carotid IMT, SBP and BMI but not correlated with serum
CRP, calcium metabolism status or serum lipid levels in
MHD patients; this is contradictory to other studies which
found negative correlation with serum calcium, phosphorus
and calcium phosphorus product. These results are contradic-
tory to results of Guerrero et al.16 who fund positive correla-
tion between calcium, CA · P, HDL but no correlation with
TGs nor phosphorus as we found. ABI is also correlated with
septum thickness and posterior wall motion as we found.
Wencheng et al.1 did not ﬁnd association between serum li-
pid levels and LVH nor with ABI although hypertriglyceride-
mia and hypercholesterolemia are associated with
cardiovascular risk in general population. Cheung et al.17 ob-
serves no statistically signiﬁcant association of cholesterol level
with peripheral vascular disease.Chronic renal failure and/or metabolic alterations second-
ary to renal failure have been suggested to promote atheroscle-
rosis. Both low ABI 6 0.9 and high IMTP 0.9 have been
shown to be independently related to increased risk of cardio-
vascular events but it is currently unclear whether measure-
ment of ABI or IMT or both is the best approach to predict
cardiovascular events in ESRD.
Our study showed correlation between carotid IMT and
LVMI as well as with SBP. These results agree with reports
showing LVH as risk factor for carotid atherosclerosis or
ischemic stroke in patients with ESRD.9 We did not ﬁnd
difference between IMT in diabetic and non diabetic group
inspite that diabetes is known to contributes to severity of
atherosclerosis and arterial stiffness in ESRD, this may be
to the small number of the studied patients.
IMT was negatively correlated with ABI, thus, IMT gives a
comprehensive picture of the alterations caused by multiple
risk factors over time on arterial walls. Prospective primary
and secondary prevention studies have also shown that in-
creased carotid IMT is a powerful predictor of coronary and
cerebrovascular complications (risk ratio from 2 to 6) with a
higher predictive value when IMT is measured at multiple
extracranial carotid sites than solely in the distal common car-
otid artery.15
There was no correlation between CRP and carotid IMT
neither with ABI in our work. This is contradictory to the re-
sults of Wencheng et al.1 who found highly signiﬁcant negative
correlation between CRP and ABI. Folsom et al.8 found a
weak positive association of CRP with carotid intima-media
thickness in both genders and with prevalent CHD in women
but in men there was a weak inverse association between CRP
and ankle/brachial blood pressure index, independent of other
risk factors, but no such association in women. Our ﬁndings
indicate that CRP is not strongly and independently associated
with prevalent atherosclerosis in hemodialysis patients. Be-
cause CRP as been associated with clinical events, it could
be that elevated CRP may be a stronger marker of thrombotic
risk than of the degree of atherosclerosis.
Generally results could differ from one study to another be-
cause of patient characteristics such as age, sex, diabetes and
study sample.
Multivariate regression analysis showed that both ABI and
IMT are both independently correlated with LVMI and both
can be used to predict the degree of LVM in patients on
hemodialysis. Wencheng et al.1 concluded that ABI was the
only independent factor associated with LVMI (IMT was
not studied in their work) but albumin, hemoglobin and hyper-
tension entered the regression equation.6. Conclusion
Both ABI and carotid IMT are equally effective to predict car-
diovascular risk as regard to LVH in hemodialysis population
and ABI should be included as a bed side cheap and reliable
way to assess cardiovascular risk in hemodialysis patients.
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